MOLINA HEALTHCARE, INC. - COMMON STOCK (MOH)

Historical Holders from Q1 2014 to Q3 2025

Symbol
MOH on NYSE
CUSIP
60855R100
Type / Class
Equity / COMMON STOCK
Shares outstanding
53.8M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
53.1M
Holdings value
$15.8B
% of all portfolios
0.006%
Grand Portfolio weight change
0%
Number of holders
617
Number of buys
320
Number of sells
-312
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.004%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of MOLINA HEALTHCARE, INC. - COMMON STOCK (MOH)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PRICE T ROWE ASSOCIATES INC /MD/ 4.1% -41.4% $370M -$273M 2.21M -42.5% T. Rowe Price Associates, Inc. Jun 30, 2025
Capital Research Global Investors 4% $363M 2.17M Capital Research Global Investors Jun 30, 2025

Institutional Holders of MOLINA HEALTHCARE, INC. - COMMON STOCK (MOH)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 1.02M $195M +$81.3M $191.36 92
2025 Q2 53.1M $15.8B -$62.8M $297.90 617
2025 Q1 53.2M $17.5B +$90.3M $329.39 610
2024 Q4 53.1M $15.5B -$720M $291.05 622
2024 Q3 55.2M $19B -$1.1B $344.56 605
2024 Q2 58.6M $17.4B +$701M $297.30 624
2024 Q1 56.2M $23.1B -$646M $410.83 617
2023 Q4 444K $160M -$4.55M $361.31 9
2023 Q3 57.1M $18.7B -$10.6M $327.89 548
2023 Q2 56.2M $16.9B +$238M $301.24 536
2023 Q1 56.5M $15.1B +$30.8M $267.49 539
2022 Q4 56.2M $18.6B +$153M $330.22 572
2022 Q3 55.6M $18.3B -$614M $329.84 540
2022 Q2 54.6M $15.2B -$235M $279.61 514
2022 Q1 56.2M $18.7B +$569M $333.59 511
2021 Q4 54.3M $17.2B -$284M $318.08 480
2021 Q3 55.3M $15B +$44.8M $271.31 428
2021 Q2 55.2M $14B -$38.8M $253.06 431
2021 Q1 55.4M $13B +$28.9M $233.76 423
2020 Q4 54.6M $11.6B -$357M $212.68 396
2020 Q3 54.1M $9.88B -$34.4M $183.04 386
2020 Q2 55.3M $9.83B -$148M $177.98 376
2020 Q1 56.1M $7.83B -$482M $139.71 296
2019 Q4 64M $8.68B +$495M $135.69 309
2019 Q3 60.4M $6.63B -$54.1M $109.72 313
2019 Q2 60.8M $8.7B -$121M $143.14 345
2019 Q1 62.7M $8.91B -$376M $141.96 340
2018 Q4 65.5M $7.61B -$126M $116.22 321
2018 Q3 66.3M $9.86B -$587M $148.70 328
2018 Q2 71.8M $7.04B +$177M $97.94 277
2018 Q1 70.5M $5.73B +$630M $81.18 240
2017 Q4 61.7M $4.73B +$214M $76.68 252
2017 Q3 60.3M $4.13B +$330M $68.76 221
2017 Q2 54.7M $3.78B +$184M $69.18 249
2017 Q1 53.3M $2.43B +$215M $45.60 234
2016 Q4 52.1M $2.83B +$39.3M $54.26 266
2016 Q3 50.5M $2.94B +$96.5M $58.32 266
2016 Q2 48.9M $2.44B +$35.7M $49.90 254
2016 Q1 47.1M $3.04B -$107M $64.49 270
2015 Q4 51M $3.07B +$134M $60.13 278
2015 Q3 48.6M $3.35B +$82.3M $68.85 292
2015 Q2 47M $3.3B +$444M $70.30 264
2015 Q1 40.6M $2.73B +$158M $67.29 227
2014 Q4 38.5M $2.06B +$82M $53.53 193
2014 Q3 36.9M $1.56B +$30.5M $42.30 183
2014 Q2 36.7M $1.64B +$105M $44.63 185
2014 Q1 34.4M $1.29B +$11.6M $37.56 169